High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

T. G. Steenbruggen; L. C. Steggink; C. M. Seynaeve; J. J.M. van der Hoeven; M. J. Hooning; A. Jager; I. R. Konings; J. R. Kroep; W. M. Smit; V. C.G. Tjan-Heijnen; E. van der Wall; A. D. Bins; S. C. Linn; M. Schaapveld; F. E. van Leeuwen; C. P. Schroder; H. van Tinteren; E. G.E. de Vries; G. S. Sonke; J. A. Gietema

doi:https://doi.org/10.1093/annonc/mdy270.184

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

T. G. Steenbruggen, L. C. Steggink, C. M. Seynaeve, J. J.M. van der Hoeven, M. J. Hooning, A. Jager, I. R. Konings, J. R. Kroep, W. M. Smit, V. C.G. Tjan-Heijnen, E. van der Wall, A. D. Bins, S. C. Linn, M. Schaapveld, F. E. van Leeuwen, C. P. Schroder, H. van Tinteren, E. G.E. de Vries, G. S. Sonke, J. A. Gietema

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii59
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy270.184
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy270.184

Cite this

Steenbruggen, T. G., Steggink, L. C., Seynaeve, C. M., van der Hoeven, J. J. M., Hooning, M. J., Jager, A., Konings, I. R., Kroep, J. R., Smit, W. M., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, A. D., Linn, S. C., Schaapveld, M., van Leeuwen, F. E., Schroder, C. P., van Tinteren, H., de Vries, E. G. E., Sonke, G. S., & Gietema, J. A. (2018). High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii59. https://doi.org/10.1093/annonc/mdy270.184

Steenbruggen, T. G. ; Steggink, L. C. ; Seynaeve, C. M. et al. / High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN) : 20-year follow-up of a randomized phase 3 study. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii59.

@article{6fc6f21358a449b19c816d77f5e4acab,

title = "High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study",

author = "Steenbruggen, {T. G.} and Steggink, {L. C.} and Seynaeve, {C. M.} and {van der Hoeven}, {J. J.M.} and Hooning, {M. J.} and A. Jager and Konings, {I. R.} and Kroep, {J. R.} and Smit, {W. M.} and Tjan-Heijnen, {V. C.G.} and {van der Wall}, E. and Bins, {A. D.} and Linn, {S. C.} and M. Schaapveld and {van Leeuwen}, {F. E.} and Schroder, {C. P.} and {van Tinteren}, H. and {de Vries}, {E. G.E.} and Sonke, {G. S.} and Gietema, {J. A.}",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy270.184",

language = "English",

volume = "29",

pages = "viii59",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Steenbruggen, TG, Steggink, LC, Seynaeve, CM, van der Hoeven, JJM, Hooning, MJ, Jager, A, Konings, IR, Kroep, JR, Smit, WM, Tjan-Heijnen, VCG, van der Wall, E, Bins, AD, Linn, SC, Schaapveld, M, van Leeuwen, FE, Schroder, CP, van Tinteren, H, de Vries, EGE, Sonke, GS & Gietema, JA 2018, 'High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii59. https://doi.org/10.1093/annonc/mdy270.184

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study. / Steenbruggen, T. G.; Steggink, L. C.; Seynaeve, C. M. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii59.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN)

T2 - 20-year follow-up of a randomized phase 3 study

AU - Steenbruggen, T. G.

AU - Steggink, L. C.

AU - Seynaeve, C. M.

AU - van der Hoeven, J. J.M.

AU - Hooning, M. J.

AU - Jager, A.

AU - Konings, I. R.

AU - Kroep, J. R.

AU - Smit, W. M.

AU - Tjan-Heijnen, V. C.G.

AU - van der Wall, E.

AU - Bins, A. D.

AU - Linn, S. C.

AU - Schaapveld, M.

AU - van Leeuwen, F. E.

AU - Schroder, C. P.

AU - van Tinteren, H.

AU - de Vries, E. G.E.

AU - Sonke, G. S.

AU - Gietema, J. A.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081530438&partnerID=8YFLogxK

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85081530438&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/32137566

U2 - https://doi.org/10.1093/annonc/mdy270.184

DO - https://doi.org/10.1093/annonc/mdy270.184

M3 - Article

C2 - 32137566

SN - 0923-7534

VL - 29

SP - viii59

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Steenbruggen TG, Steggink LC, Seynaeve CM, van der Hoeven JJM, Hooning MJ, Jager A et al. High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii59. doi: https://doi.org/10.1093/annonc/mdy270.184

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

Access to Document

Other files and links

Cite this